{
    "pmcid": "11794456",
    "qa_pairs": {
        "How does DeepPFP improve prediction performance for SARS-CoV-2 nanobody design?": [
            "By using ESM to enhance binding affinity predictions",
            "By employing a larger dataset for training",
            "By focusing solely on the spike protein without external validation",
            "By ignoring sequence variations in the RBD"
        ],
        "What is one of the key benefits of combining ESM with MAML in the context of SARS-CoV-2?": [
            "Rapid adaptation to new protein variants",
            "Increased computational efficiency",
            "Reduced need for labeled data",
            "Enhanced visualization of protein structures"
        ],
        "What is the primary architecture used in ESM as described in the paper?": [
            "Transformer Encoder",
            "Convolutional Neural Network",
            "Recurrent Neural Network",
            "Support Vector Machine"
        ],
        "What metric is mentioned as being improved by integrating ESM into the DeepPFP framework?": [
            "Pearson\u2019s correlation coefficient (PCC)",
            "Mean squared error (MSE)",
            "F1 score",
            "Area under the ROC curve (AUC)"
        ],
        "What specific dataset is used for external validation in the study?": [
            "Deep mutational scanning dataset of the SARS-CoV-2 Spike protein RBD",
            "Cryo-EM structure dataset of the SARS-CoV-2 Spike protein",
            "X-ray crystallography dataset of the SARS-CoV-2 Nucleocapsid protein",
            "Genomic sequencing dataset of SARS-CoV-2 variants"
        ]
    }
}